• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本原发性硬化性胆管炎——192例分析

Primary sclerosing cholangitis in Japan--analysis of 192 cases.

作者信息

Takikawa H, Manabe T

机构信息

Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.

出版信息

J Gastroenterol. 1997 Feb;32(1):134-7. doi: 10.1007/BF01213311.

DOI:10.1007/BF01213311
PMID:9058310
Abstract

Primary sclerosing cholangitis is very rare in Japan. The aim of the present study was to identify the characteristics of such patients in Japan. A questionnaire was sent to the members of the Japanese Society of Gastroenterology and responses for 192 cases were analyzed. There was male predominancy (61%), and two peaks in the age distribution at diagnosis (20-30 years and 50-70 years). Bile duct damage was mainly intra + extrahepatic (69%) versus intrahepatic (17%) or extrahepatic (14%). The incidences of eosinophilia and positivity for anti-nuclear antibody were 27% and 30%, respectively. The incidence of associated inflammatory bowel disease was 21% (38 ulcerative colitis and 2 Crohn's disease). Chronic pancreatitis, gallstones, and biliary cancers occurred in 15%, 12%, and 4%, respectively, of the 192 patients. Patients less than 40 years of age had a higher incidence than the patients 40 years old or more of damage intra + extrahepatic bile ducts (89% vs 56%) and of associated ulcerative colitis (36% vs 9%), whereas the incidence of chronic pancreatitis was lower in patients aged less than 40 years (4%). The characteristics of patients with primary sclerosing cholangitis in Japan differ from those in other countries in regard to age distribution and the incidence of complications, and at least two different groups of patients seem to exist in terms of the degree of bile duct damage and the incidence of complications.

摘要

原发性硬化性胆管炎在日本非常罕见。本研究的目的是确定日本此类患者的特征。向日本胃肠病学会成员发送了一份调查问卷,并对192例患者的回复进行了分析。男性占主导(61%),诊断时年龄分布有两个高峰(20 - 30岁和50 - 70岁)。胆管损伤主要为肝内 + 肝外(69%),而肝内(17%)或肝外(14%)损伤较少。嗜酸性粒细胞增多症和抗核抗体阳性的发生率分别为27%和30%。合并炎症性肠病的发生率为21%(38例溃疡性结肠炎和2例克罗恩病)。192例患者中,慢性胰腺炎、胆结石和胆管癌的发生率分别为15%、12%和4%。年龄小于40岁的患者肝内 + 肝外胆管损伤(89%对56%)和合并溃疡性结肠炎(36%对9%)的发生率高于40岁及以上患者,而年龄小于40岁的患者慢性胰腺炎的发生率较低(4%)。日本原发性硬化性胆管炎患者在年龄分布和并发症发生率方面与其他国家不同,并且在胆管损伤程度和并发症发生率方面似乎至少存在两组不同的患者。

相似文献

1
Primary sclerosing cholangitis in Japan--analysis of 192 cases.日本原发性硬化性胆管炎——192例分析
J Gastroenterol. 1997 Feb;32(1):134-7. doi: 10.1007/BF01213311.
2
Recent status of primary sclerosing cholangitis in Japan.日本原发性硬化性胆管炎的现状
J Hepatobiliary Pancreat Surg. 1999;6(4):352-5. doi: 10.1007/s005340050129.
3
Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects.与炎症性肠病相关的原发性硬化性胆管炎与无炎症性肠病时发生的原发性硬化性胆管炎有差异吗?一项针对66名受试者的研究。
Hepatology. 1990 Jan;11(1):7-11. doi: 10.1002/hep.1840110103.
4
Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.原发性硬化性胆管炎和自身免疫性硬化性胆管炎中慢性炎症性肠病的对比模式
EBioMedicine. 2015 Sep 2;2(10):1523-7. doi: 10.1016/j.ebiom.2015.08.041. eCollection 2015 Oct.
5
Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran.伊朗原发性硬化性胆管炎患者中炎症性肠病的患病率。
Arab J Gastroenterol. 2016 Mar;17(1):17-9. doi: 10.1016/j.ajg.2015.09.004. Epub 2016 Mar 28.
6
Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.炎症性肠病和原发性硬化性胆管炎患者抗中性粒细胞抗体的临床意义
Gut. 1992 May;33(5):657-62. doi: 10.1136/gut.33.5.657.
7
Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.克罗恩病结肠炎和原发性硬化性胆管炎患者结直肠癌和异型增生的风险增加。
Dis Colon Rectum. 2011 Nov;54(11):1392-7. doi: 10.1097/DCR.0b013e31822bbcc1.
8
Geoepidemiology of primary sclerosing cholangitis: a critical review.原发性硬化性胆管炎的地理流行病学:批判性评价。
J Autoimmun. 2013 Oct;46:35-40. doi: 10.1016/j.jaut.2013.07.005. Epub 2013 Aug 7.
9
Three cases of primary sclerosing cholangitis associated with ulcerative colitis; diagnostic usefulness of magnetic resonance cholangiopancreatography.三例原发性硬化性胆管炎合并溃疡性结肠炎;磁共振胰胆管造影的诊断价值
Hepatogastroenterology. 2002 Mar-Apr;49(44):317-21.
10
Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver.西班牙原发性硬化性胆管炎的流行病学。西班牙肝脏研究协会。
J Hepatol. 1994 Nov;21(5):787-91. doi: 10.1016/s0168-8278(94)80240-8.

引用本文的文献

1
Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies.原发性硬化性胆管炎相关胆管癌:从发病机制到诊断与监测策略
Cancers (Basel). 2023 Oct 11;15(20):4947. doi: 10.3390/cancers15204947.
2
Risk factors for the postoperative recurrence of ulcerative colitis-associated colorectal cancer.溃疡性结肠炎相关结直肠癌术后复发的危险因素。
Int J Colorectal Dis. 2023 May 4;38(1):113. doi: 10.1007/s00384-023-04410-z.
3
The microbiota and the gut-liver axis in primary sclerosing cholangitis.

本文引用的文献

1
Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period.熊去氧胆酸对原发性硬化性胆管炎肝脏及胆管疾病的影响。一项为期3年的先导性研究,设有安慰剂对照研究期。
J Hepatol. 1994 Jan;20(1):57-64. doi: 10.1016/s0168-8278(05)80467-2.
2
Risk factors in primary sclerosing cholangitis.原发性硬化性胆管炎的危险因素
J Hepatol. 1994 Dec;21(6):1061-6. doi: 10.1016/s0168-8278(05)80618-x.
3
Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis.
原发性硬化性胆管炎中的微生物群与肠-肝轴
Nat Rev Gastroenterol Hepatol. 2023 Mar;20(3):135-154. doi: 10.1038/s41575-022-00690-y. Epub 2022 Nov 9.
4
Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population.原发性硬化性胆管炎在高度混合的巴西人群中的临床特征和结局。
Can J Gastroenterol Hepatol. 2021 Nov 10;2021:7746401. doi: 10.1155/2021/7746401. eCollection 2021.
5
Elective staged proctocolectomy and living donor liver transplantation for colon cancer with sclerosing cholangitis-related ulcerative colitis: a case report.择期分期直肠结肠切除术及活体供肝肝移植治疗合并硬化性胆管炎相关溃疡性结肠炎的结肠癌:1例报告
Surg Case Rep. 2020 Nov 1;6(1):278. doi: 10.1186/s40792-020-01059-6.
6
Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation.原发性硬化性胆管炎相关性结肠炎:临床、组织学特征及其与肝移植的关系。
World J Gastroenterol. 2020 Jul 28;26(28):4126-4139. doi: 10.3748/wjg.v26.i28.4126.
7
British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.英国胃肠病学会和英国PSC 指南:原发性硬化性胆管炎的诊断和管理。
Gut. 2019 Aug;68(8):1356-1378. doi: 10.1136/gutjnl-2018-317993. Epub 2019 Jun 1.
8
Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.炎症性肠病合并原发性硬化性胆管炎患者的特征
J Clin Med Res. 2019 Feb;11(2):81-88. doi: 10.14740/jocmr3680. Epub 2019 Jan 5.
9
Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients.原发性硬化性胆管炎和溃疡性结肠炎在日本患者中的临床特征和结局。
PLoS One. 2018 Dec 20;13(12):e0209352. doi: 10.1371/journal.pone.0209352. eCollection 2018.
10
Clinical guidelines for primary sclerosing cholangitis 2017.2017 年原发性硬化性胆管炎临床指南。
J Gastroenterol. 2018 Sep;53(9):1006-1034. doi: 10.1007/s00535-018-1484-9. Epub 2018 Jun 27.
人类淋巴细胞-DR2抗原与日本溃疡性结肠炎的关联。
Gastroenterology. 1982 Mar;82(3):413-8.
4
Current concepts. Primary sclerosing cholangitis.当前概念。原发性硬化性胆管炎。
N Engl J Med. 1984 Apr 5;310(14):899-903. doi: 10.1056/NEJM198404053101407.
5
A case of primary sclerosing cholangitis.一例原发性硬化性胆管炎病例。
Gastroenterol Jpn. 1985 Aug;20(4):368-73. doi: 10.1007/BF02774748.
6
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis.原发性硬化性胆管炎:自然史、预后因素及生存分析。
Hepatology. 1989 Oct;10(4):430-6. doi: 10.1002/hep.1840100406.
7
Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects.与炎症性肠病相关的原发性硬化性胆管炎与无炎症性肠病时发生的原发性硬化性胆管炎有差异吗?一项针对66名受试者的研究。
Hepatology. 1990 Jan;11(1):7-11. doi: 10.1002/hep.1840110103.
8
Surgical aspects of sclerosing cholangitis. Results in 178 patients.硬化性胆管炎的外科手术相关情况。178例患者的结果。
Ann Surg. 1990 Oct;212(4):551-6; discussion 556-8. doi: 10.1097/00000658-199010000-00017.
9
Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients.日本患者自身免疫性肝炎与HLA - Bw54和DR4的关联。
Hepatology. 1990 Dec;12(6):1300-4. doi: 10.1002/hep.1840120609.
10
Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study.熊去氧胆酸治疗原发性硬化性胆管炎:一项为期30个月的试点研究。
Hepatology. 1991 Nov;14(5):838-47. doi: 10.1002/hep.1840140516.